Abstract
Science-based businesses are taking a new dimension today.
Biotechnological innovations and inventions are given much attention in transforming
laboratory findings into business. Vaccine technology, since the pandemic 2019, has
become a billion-dollar business. An integrated approach of nanotechnology and
biotechnology as a single unit called Nano biotechnology opens a promising avenue for
business opportunities in health care. After the SARS-CoV-2 threat emerged, intensive
searches were accelerated to find remedial measures from different systems of
medicine. In this search, nanoparticles of both organic and inorganic origin are
prioritized, and research in nano -biotechnology gets immediate attention. Laboratory
research is intensified to formulate and patent some products to fight against the
coronavirus attack. Bio-inspired inorganic nanoparticles are reasonable in using
nanoparticles as a workhorse for biomedical applications. The biosynthesized
nanoparticles and quantum dots of gold, silver, cadmium, titanium, etc., have multiple
biomedical applications. The biogenic nanometal products enhance immunity, fight
against viruses, help in diagnosis, and play a role in preparing antiviral dressings, face
masks, and drug carriers. This venture promotes promising business avenues.
Biopharma industries are interested in developing the nanotechnology-based
therapeutic drug dexamethasone for SARS-CoV-2 drugs; nano-based vaccination to
boost immune responses is also progressing. The global market for nanobiotechnology
is expected to reach $68.4 billion by 2026. As nanobiotechnology-based business is
becoming a promising area for start-ups and entrepreneurs, the stakeholders can utilize
the opportunity as quoted “make hay while the sun shines”.